PNKD antibody (N-Term)
Quick Overview for PNKD antibody (N-Term) (ABIN954223)
Target
See all PNKD AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 41-70, N-Term
-
Specificity
- This antibody recognizes Human and Mouse PNKD (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 41-70 amino acids from the N-terminal region of human PNKD
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PNKD (Paroxysmal Nonkinesigenic Dyskinesia (PNKD))
-
Alternative Name
- PNKD
-
Background
- This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants.Synonyms: FKSG19, KIAA1184, MR-1, MR1, Myofibrillogenesis regulator 1, Paroxysmal nonkinesiogenic dyskinesia protein, Probable hydrolase PNKD, TAHCCP2, Trans-activated by hepatitis C virus core protein 2, UNQ2491/PRO5778
-
Molecular Weight
- 42876 Da
-
Gene ID
- 25953
-
NCBI Accession
- NP_001070867
Target
-